Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 19502586)

Published in Int Immunol on June 05, 2009

Authors

Ghania Chikh1, Susan D de Jong, Laura Sekirov, Sameersingh G Raney, Mikameh Kazem, Kaley D Wilson, Pieter R Cullis, Jan P Dutz, Ying K Tam

Author Affiliations

1: Tekmira Pharmaceuticals Corporation, British Columbia, Canada.

Articles by these authors

Drug delivery systems: entering the mainstream. Science (2004) 9.27

Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97

Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36

Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev (2012) 4.30

Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl (2012) 1.87

The liposomal formulation of doxorubicin. Methods Enzymol (2005) 1.62

Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine (2009) 1.50

Usefulness of Interferon-γ release assays in the diagnosis of erythema induratum. Arch Dermatol (2011) 1.40

In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol (2002) 1.30

Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26

Liposomal nanomedicines. Expert Opin Drug Deliv (2008) 1.26

New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther (2007) 1.24

Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23

Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex. Sci Transl Med (2012) 1.21

Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20

Optimization of epicutaneous immunization for the induction of CTL. Vaccine (2003) 1.19

Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol (2006) 1.17

Better influenza vaccines for older people: what will it take? J Infect Dis (2008) 1.17

Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA. Mol Ther Nucleic Acids (2012) 1.16

Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing. Langmuir (2012) 1.13

Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release (2005) 1.12

Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol Ther (2013) 1.11

Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol (2007) 1.11

Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy. Adv Drug Deliv Rev (2009) 1.09

TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN. Cancer Immunol Immunother (2007) 1.08

Cytokines in the generation and maturation of dendritic cells: recent advances. Eur Cytokine Netw (2002) 1.08

Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04

Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim Biophys Acta (2006) 1.04

Liposomal nanomedicines: an emerging field. Toxicol Pathol (2008) 1.01

Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol (2006) 1.00

Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00

Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95

Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol (2013) 0.94

Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. J Phys Chem C Nanomater Interfaces (2012) 0.93

Topical CpG enhances the response of murine malignant melanoma to dacarbazine. J Invest Dermatol (2008) 0.93

Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain. Mol Ther Nucleic Acids (2013) 0.92

Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. J Pharm Sci (2005) 0.92

Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92

Reversible retiform purpura: a sign of cocaine use. CMAJ (2011) 0.92

Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention. J Control Release (2005) 0.91

Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin. Biochim Biophys Acta (2007) 0.90

Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo. Int J Cancer (2012) 0.90

Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J Invest Dermatol (2004) 0.89

Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles. Int Immunopharmacol (2007) 0.89

Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells. Bioconjug Chem (2009) 0.88

Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles. ACS Nano (2015) 0.88

The immunostimulatory activity of unmethylated and methylated CpG oligodeoxynucleotide is dependent on their ability to colocalize with TLR9 in late endosomes. J Immunol (2010) 0.88

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles. J Control Release (2010) 0.87

Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochim Biophys Acta (2003) 0.87

Influence of drug-to-lipid ratio on drug release properties and liposome integrity in liposomal doxorubicin formulations. J Liposome Res (2008) 0.86

Stabilized plasmid-lipid particles: a systemic gene therapy vector. Methods Enzymol (2002) 0.86

Treatment of atypical nevi with imiquimod 5% cream. Arch Dermatol (2007) 0.85

Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies. J Biol Chem (2013) 0.85

Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85

Advances in Lipid Nanoparticles for siRNA Delivery. Pharmaceutics (2013) 0.85

Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being. J Rheumatol Suppl (2011) 0.85

Entrapment of small molecules and nucleic acid-based drugs in liposomes. Methods Enzymol (2005) 0.84

Tunable pH-sensitive liposomes. Methods Enzymol (2004) 0.83

IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod (2008) 0.83

Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol (2012) 0.83

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA. Biochem J (2007) 0.83

Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Methods Enzymol (2005) 0.82

Alkylated derivatives of poly(ethylacrylic acid) can be inserted into preformed liposomes and trigger pH-dependent intracellular delivery of liposomal contents. Mol Membr Biol (2005) 0.82

Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev (2009) 0.82

Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Eur J Immunol (2007) 0.82

Triggered release of doxorubicin following mixing of cationic and anionic liposomes. Biochim Biophys Acta (2002) 0.81

Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int Immunol (2004) 0.80

Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. J Liposome Res (2004) 0.80

Calcium enhances the transfection potency of stabilized plasmid-lipid particles. Anal Biochem (2005) 0.80

Development of high-concentration lipoplexes for in vivo gene function studies in vertebrate embryos. Dev Dyn (2011) 0.79

The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine. J Gene Med (2009) 0.78

Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. Biol Blood Marrow Transplant (2011) 0.78

Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine (2004) 0.78

Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA. Nanomedicine (2012) 0.78

Skin immune responses to peptide and protein antigen are TLR4 independent. Cell Immunol (2003) 0.78

Decidual NK cell-derived conditioned medium (dNK-CM) mediates VEGF-C secretion in extravillous cytotrophoblasts. Am J Reprod Immunol (2011) 0.77

Capillary electrophoresis frontal analysis for characterization of alphavbeta3 integrin binding interactions. Anal Chem (2008) 0.77

Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care (2014) 0.77

Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA. Nanomedicine (2012) 0.77

Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77

Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol (2007) 0.77

Synthesis and properties of novel tetraalkyl cationic lipids. Bioconjug Chem (2002) 0.77

Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl (2011) 0.77